Opinion
Video
Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer
Author(s):
GU medical oncologist Dr. Rana McKay and urologist Dr. Neal Shore explore how predictive biomarkers and genetic testing are informing risk assessment and guiding personalized treatment decisions in clinical practice
EP: 1.Metastatic Prostate Cancer: Background and Patient Prognosis
Now Viewing
EP: 2.Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer
EP: 3.Treatment Selection in Metastatic and Castration Resistant Prostate Cancer Optimizing Outcomes and Preserving Patient Quality of Life
EP: 4.Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis
EP: 5.Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer
EP: 6.Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape
EP: 7.Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer
Related Videos
Related Content
%201%20(1)-Recovered%20copy.jpg?fit=crop&auto=format)
%201%20(1)-Recovered%20copy.jpg?fit=crop&auto=format)
